Details of the Drug

General Information of Drug (ID: DMSDGEJ)

• Drug Name: OP0201

Indication

Disease Entry	ICD 11	Status	REF
Acute otitis media	AB00	Phase 2	[1]

• Cross-matching ID: TTD ID: DT30ZG

References

• [1] ClinicalTrials.gov (NCT03818815) A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months. U.S.National Institutes of Health.